192 related articles for article (PubMed ID: 26211581)
1. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri.
Yang M; Li N; Li F; Zhu Q; Liu X; Han Q; Wang Y; Chen Y; Zeng X; Lv Y; Zhang P; Yang C; Liu Z
Int Immunopharmacol; 2013 Aug; 16(4):466-74. PubMed ID: 23669332
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro.
Liu M; Yin H; Liu G; Dong J; Qian Z; Miao J
J Agric Food Chem; 2014 Jun; 62(24):5548-54. PubMed ID: 24897556
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer.
Saito K; Matsuo Y; Imafuji H; Okubo T; Maeda Y; Sato T; Shamoto T; Tsuboi K; Morimoto M; Takahashi H; Ishiguro H; Takiguchi S
Cancer Sci; 2018 Jan; 109(1):132-140. PubMed ID: 29121426
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.
Dorn C; Kraus B; Motyl M; Weiss TS; Gehrig M; Schölmerich J; Heilmann J; Hellerbrand C
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S205-13. PubMed ID: 20087858
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.
Dokduang H; Yongvanit P; Namwat N; Pairojkul C; Sangkhamanon S; Yageta MS; Murakami Y; Loilome W
Oncol Rep; 2016 Apr; 35(4):2065-72. PubMed ID: 26794001
[TBL] [Abstract][Full Text] [Related]
7. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).
Peluso MR; Miranda CL; Hobbs DJ; Proteau RR; Stevens JF
Planta Med; 2010 Oct; 76(14):1536-43. PubMed ID: 20309792
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol inhibits cell proliferation and induces apoptosis in human thyroid cells.
Carvalho DO; Freitas J; Nogueira P; Henriques SN; Carmo AM; Castro MA; Guido LF
Food Chem Toxicol; 2018 Nov; 121():450-457. PubMed ID: 30240731
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines.
Delmulle L; Bellahcène A; Dhooge W; Comhaire F; Roelens F; Huvaere K; Heyerick A; Castronovo V; De Keukeleire D
Phytomedicine; 2006 Nov; 13(9-10):732-4. PubMed ID: 16678392
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
Dorn C; Weiss TS; Heilmann J; Hellerbrand C
Int J Oncol; 2010 Feb; 36(2):435-41. PubMed ID: 20043079
[TBL] [Abstract][Full Text] [Related]
11. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
[TBL] [Abstract][Full Text] [Related]
12. Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.
Liu M; Yin H; Qian X; Dong J; Qian Z; Miao J
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036030
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
Wei S; Sun T; Du J; Zhang B; Xiang D; Li W
Oncol Rep; 2018 Dec; 40(6):3213-3222. PubMed ID: 30272303
[TBL] [Abstract][Full Text] [Related]
14. Xanthohumol, a prenylated chalcone derived from hops, suppresses cancer cell invasion through inhibiting the expression of CXCR4 chemokine receptor.
Wang Y; Chen Y; Wang J; Chen J; Aggarwal BB; Pang X; Liu M
Curr Mol Med; 2012 Feb; 12(2):153-62. PubMed ID: 22172099
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.
Shikata Y; Yoshimaru T; Komatsu M; Katoh H; Sato R; Kanagaki S; Okazaki Y; Toyokuni S; Tashiro E; Ishikawa S; Katagiri T; Imoto M
Cancer Sci; 2017 Apr; 108(4):785-794. PubMed ID: 28122154
[TBL] [Abstract][Full Text] [Related]
16. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells.
Colgate EC; Miranda CL; Stevens JF; Bray TM; Ho E
Cancer Lett; 2007 Feb; 246(1-2):201-9. PubMed ID: 16563612
[TBL] [Abstract][Full Text] [Related]
17. Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.
Zhang W; Pan Y; Gou P; Zhou C; Ma L; Liu Q; Du Y; Yang J; Wang Q
Oncol Rep; 2018 Jan; 39(1):280-288. PubMed ID: 29138867
[TBL] [Abstract][Full Text] [Related]
18. Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.
Gallo C; Dallaglio K; Bassani B; Rossi T; Rossello A; Noonan DM; D'Uva G; Bruno A; Albini A
Oncotarget; 2016 Sep; 7(37):59917-59931. PubMed ID: 27494895
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.
Deeb D; Gao X; Jiang H; Arbab AS; Dulchavsky SA; Gautam SC
Anticancer Res; 2010 Sep; 30(9):3333-9. PubMed ID: 20944105
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.
Nuti E; Bassani B; Camodeca C; Rosalia L; Cantelmo A; Gallo C; Baci D; Bruno A; Orlandini E; Nencetti S; Noonan DM; Albini A; Rossello A
Eur J Med Chem; 2017 Sep; 138():890-899. PubMed ID: 28750311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
